These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 11961556)
1. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Drenkard E; Ausubel FM Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556 [TBL] [Abstract][Full Text] [Related]
2. Microbiology: a resistance switch. O'Toole GA Nature; 2002 Apr; 416(6882):695-6. PubMed ID: 11961541 [No Abstract] [Full Text] [Related]
3. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272 [TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
5. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055 [TBL] [Abstract][Full Text] [Related]
6. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis]. Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909 [TBL] [Abstract][Full Text] [Related]
8. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada. Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]
14. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. Salunkhe P; Smart CH; Morgan JA; Panagea S; Walshaw MJ; Hart CA; Geffers R; Tümmler B; Winstanley C J Bacteriol; 2005 Jul; 187(14):4908-20. PubMed ID: 15995206 [TBL] [Abstract][Full Text] [Related]